Tarsier™ Pharma (doing business as Tarsius Pharma Ltd.) is a clinical late stage company developing a novel treatment for uveitis, an autoimmune disease of the eye, and the 3rd leading cause for blindness. The new therapy is based on a new technology inspired by nature.